Towards Healthcare
Carrier Screening Market to Rise at 19.65% CAGR till 2034

Carrier Screening Market Future Demand Driven by IVF Growth

Market insights predict, the carrier screening industry is expected to grow from USD 2.58 billion in 2024 to USD 15.5 billion by 2034, driven by a CAGR of 19.65%.  An immense growth in prenatal screening programs and early detection is mainly influencing the global market expansion. Whereas, the presence of robust healthcare policies and systems is fueling North America’s market development.

Content

  • Insight Code: 6062
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The carrier screening market is valued at USD 3.09 billion in 2025 and is on track to reach USD 15.5 billion by 2034, witnessing a steady CAGR of 19.65% during the forecast span.

North America is currently leading the carrier screening market share 42% due to its robust healthcare policies and infrastructure.

The carrier screening market includes six segments such as by test type, by technology, by indication, by end use, by patient group, and by region.

Some key players include Illumina Inc., Thermo Fisher Scientific Inc., Natera Inc., Myriad Genetics Inc., and Invitae Corporation.

Carrier screening can be done in preconception, during pregnancy, and before IVF.

Screening tests are important in IVF as they offer fertility assessment, monitoring egg maturation, and improving success rates.

NHGRI, NIH, US FDA, CGE, ClinicalTrials.gov, WA.GOV, CDC, PIB, NCI, NSW, etc.
Any Questions